Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Rothe

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
New Biotechnology|April 9, 2011
Recombinant proteins in rheumatology - recent advancesAchim Rothe, Andrea Rubbert
Expert Opinion on Biological Therapy|June 25, 2013
Monoclonal antibody treatments for rheumatoid arthritisLukas Bossaller, Achim Rothe
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2014
Multi-specific antibodies for cancer immunotherapyRon D Jachimowicz, Sven Borchmann, Achim Rothe
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 29, 2006
In vitro display technologies reveal novel biopharmaceuticsAchim Rothe, Ralf J Hosse, Barbara E Power
Trends in Biotechnology|October 24, 2006
Novel proteins in emulsions using in vitro compartmentalizationAchim Rothe, Regina N Surjadi, Barbara E Power
Expert Opinion on Biological Therapy|January 27, 2006
Ribosome display for improved biotherapeutic moleculesAchim Rothe, Ralf J Hosse, Barbara E Power
Nature Clinical Practice. Rheumatology|September 25, 2008
Therapeutic advances in rheumatology with the use of recombinant proteinsAchim Rothe, Barbara E Power, Peter J Hudson
Protein Science : a Publication of the Protein Society|December 24, 2005
A new generation of protein display scaffolds for molecular recognitionRalf J Hosse, Achim Rothe, Barbara E Power
Haematologica|July 20, 2004
Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphomaAchim Rothe, Holger Schulz, Thomas Elter, et al.
Cancer Treatment and Research Communications|March 22, 2025
Targeted therapy for non-small cell lung cancer (NSCLC) in a real-world setting: A single practice experienceAchim Rothe, Nathalie Bauer, Lutz Dietze, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
New Biotechnology|April 9, 2011
Recombinant proteins in rheumatology - recent advancesAchim Rothe, Andrea Rubbert
Expert Opinion on Biological Therapy|June 25, 2013
Monoclonal antibody treatments for rheumatoid arthritisLukas Bossaller, Achim Rothe
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 19, 2014
Multi-specific antibodies for cancer immunotherapyRon D Jachimowicz, Sven Borchmann, Achim Rothe
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 29, 2006
In vitro display technologies reveal novel biopharmaceuticsAchim Rothe, Ralf J Hosse, Barbara E Power
Trends in Biotechnology|October 24, 2006
Novel proteins in emulsions using in vitro compartmentalizationAchim Rothe, Regina N Surjadi, Barbara E Power
Expert Opinion on Biological Therapy|January 27, 2006
Ribosome display for improved biotherapeutic moleculesAchim Rothe, Ralf J Hosse, Barbara E Power
Nature Clinical Practice. Rheumatology|September 25, 2008
Therapeutic advances in rheumatology with the use of recombinant proteinsAchim Rothe, Barbara E Power, Peter J Hudson
Protein Science : a Publication of the Protein Society|December 24, 2005
A new generation of protein display scaffolds for molecular recognitionRalf J Hosse, Achim Rothe, Barbara E Power
Haematologica|July 20, 2004
Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphomaAchim Rothe, Holger Schulz, Thomas Elter, et al.
Cancer Treatment and Research Communications|March 22, 2025
Targeted therapy for non-small cell lung cancer (NSCLC) in a real-world setting: A single practice experienceAchim Rothe, Nathalie Bauer, Lutz Dietze, et al.
Pageof 4